Recombinant Protein and Antibody Production Services for Protein Therapeutics

Companies that provide these services can generate protein and antibody products as well as perform process development and scale-up of such products. Providers offer services to increase protein and antibody product yields, decrease process development time, and improve product stability. Other specialty services offered can include vector construction, stable mammalian cell line generation, small- and large-scale transient production, upstream and downstream process development and scale-up, medium selection, feed strategy optimization, analytical development, product characterization and cGMP manufacturing.